Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 7Not yet recruiting 5Completed 5Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 42Breast Neoplasms 32Neoplasms 29Melanoma 22Neoplasm Metastasis 21Leukemia, Myeloid, Acute 21Multiple Myeloma 17Lung Neoplasms 17Prostatic Neoplasms 16Colorectal Neoplasms 16Ovarian Neoplasms 14Myelodysplastic Syndromes 13Squamous Cell Carcinoma of Head and Neck 12Recurrence 12Lymphoma, Non-Hodgkin 12Carcinoma, Renal Cell 11Pancreatic Neoplasms 10Lymphoma, Large B-Cell, Diffuse 10Glioblastoma 10Brain Neoplasms 10Urinary Bladder Neoplasms 9Uterine Cervical Neoplasms 8Stomach Neoplasms 8Carcinoma, Hepatocellular 8Rectal Neoplasms 7Lymphoma 7Hodgkin Disease 7Head and Neck Neoplasms 7Glioma 7Endometrial Neoplasms 7

Interventions

Letrozole 1Lead 1Goserelin 1Fulvestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Advanced Breast Cancer × 90 days × Clear all
NCT05085002 2026-05-14

A Study of Lerociclib in Participants With Advanced Breast Cancer

EQRx International, Inc.

Phase 2 Terminated
100 enrolled 14 charts
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡